NO20052264D0 - Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser - Google Patents

Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser

Info

Publication number: NO20052264D0
Authority: NO; Norway
Prior art keywords: pregahalin; fibromyalgia; disorders; derivatives; treatment
Prior art date: 2002-12-13

Application number

NO20052264A

Other languages

English (en)

Other versions

NO20052264L (no

Inventor

David Juergen Wustrow

Jr Charles Price Taylor

Andrew John Thorpe

David James Dooley

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-13

Filing date

2005-05-10

Publication date

2005-05-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32600153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20052264(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-10 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2005-05-10 Publication of NO20052264D0 publication Critical patent/NO20052264D0/no

2005-09-12 Publication of NO20052264L publication Critical patent/NO20052264L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20052264A 2002-12-13 2005-05-10 Pregabalinderivater for behandling av fibromyalgi og andre forstyrrelser NO20052264L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US43349102P	2002-12-13	2002-12-13
US48774003P	2003-07-16	2003-07-16
PCT/IB2003/005712 WO2004054566A1 (en)	2002-12-13	2003-12-03	Pregabalin derivatives for the treatment of fibromyalgia and other disorders

Publications (2)

Publication Number	Publication Date
NO20052264D0 true NO20052264D0 (no)	2005-05-10
NO20052264L NO20052264L (no)	2005-09-12

Family

ID=32600153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052264A NO20052264L (no)	2002-12-13	2005-05-10	Pregabalinderivater for behandling av fibromyalgi og andre forstyrrelser

Country Status (15)

Country	Link
US (1)	US20090203782A1 (no)
EP (2)	EP2172197A1 (no)
JP (1)	JP2006513257A (no)
KR (1)	KR20050085636A (no)
CN (1)	CN101862317A (no)
AU (1)	AU2003303040B2 (no)
BR (1)	BR0317253A (no)
CA (1)	CA2505788A1 (no)
MX (1)	MXPA05006320A (no)
NO (1)	NO20052264L (no)
NZ (1)	NZ540591A (no)
PL (1)	PL377520A1 (no)
RU (2)	RU2353358C2 (no)
TW (1)	TW200423925A (no)
WO (1)	WO2004054566A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05010515A (es)	2003-03-31	2006-03-10	Xenoport Inc	Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
RU2006107534A (ru) *	2003-09-12	2007-09-20	Уорнер-Ламберт Компани Ллс (Us)	Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства
US20070141684A1 (en)	2005-12-21	2007-06-21	Pfizer Inc	Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
SG11201606351VA (en)	2014-02-03	2016-09-29	Quadriga Biosciences Inc	Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
JP6271766B2 (ja) *	2014-02-03	2018-01-31	クワドリガバイオサイエンシーズ，インコーポレイテッド	化学療法剤としてのβ置換γアミノ酸および類似体
EP3331851A1 (en)	2015-08-03	2018-06-13	Quadriga Biosciences, Inc.	Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
CN115739134B (zh) *	2022-11-24	2024-08-02	贵州大学	一种利用三氯化钌废弃物制备氯乙烯合成用复合催化剂的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087544A (en)	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de)	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1993023383A1 (en)	1992-05-20	1993-11-25	Northwestern University	Gaba and l-glutamic acid analogs for antiseizure treatment
TW336932B (en)	1992-12-17	1998-07-21	Pfizer	Amino-substituted pyrazoles
JP2862374B2 (ja)	1992-12-17	1999-03-03	フアイザー・インコーポレイテツド	Ｃｒｆアンタゴニスト活性を有するピラゾール及びピラゾロピリミジン
CZ286892B6 (en)	1992-12-17	2000-07-12	Pfizer	Pyrrolopyrimidine compounds, intermediates for their preparation and pharmaceutical preparations based thereon
CA2150703C (en)	1992-12-17	2002-01-08	Pfizer Limited	Substituted pyrazoles
TW370529B (en)	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
US5670539A (en) *	1993-07-21	1997-09-23	New York State Office Of Mental Health	Treatment of movement disorders using large neutral amino acids
US6372792B1 (en) *	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
ATE241351T1 (de) *	1996-07-24	2003-06-15	Warner Lambert Co	Isobutylgaba und dessen derivate zur schmerzbehandlung
SE9603408D0 (sv) *	1996-09-18	1996-09-18	Astra Ab	Medical use
US6153650A (en)	1996-10-23	2000-11-28	Warner-Lambert Company	Substituted gamma aminobutyric acids as pharmaceutical agents
US6127418A (en) *	1997-08-20	2000-10-03	Warner-Lambert Company	GABA analogs to prevent and treat gastrointestinal damage
CN1303059C (zh)	1997-10-27	2007-03-07	沃尼尔·朗伯公司	作为药物的环状氨基酸及其衍生物
US6306910B1 (en)	1998-07-09	2001-10-23	Warner-Lambert Company	Use of Gaba-analogues for treating insomnia
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DK1169060T3 (da) *	1999-04-09	2006-01-16	Euro Celtique Sa	Natriumkanalblokkerpræparater og anvendelse deraf
US7164034B2 (en) *	1999-06-10	2007-01-16	Pfizer Inc.	Alpha2delta ligands for fibromyalgia and other disorders
US6642398B2 (en) *	1999-06-10	2003-11-04	Warner-Lambert Company	Mono-and disubstituted 3-propyl gamma-aminobutyric acids
DE60041256D1 (de)	1999-06-10	2009-02-12	Warner Lambert Co	Mono-substituierte 3-propyl-gamma-aminobuttersäure
US6309663B1 (en) *	1999-08-17	2001-10-30	Lipocine Inc.	Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
WO2001007037A1 (en) *	1999-07-22	2001-02-01	University Of Rochester	Method of treating symptoms of hormonal variation, including hot flashes
US6281207B1 (en) *	1999-09-15	2001-08-28	Reed Richter	Treatment of movement disorders by administration of mirtazapine
HN2000000224A (es)	1999-10-20	2001-04-11	Warner Lambert Co	Aminoacidos biciclicos como agentes farmaceuticos
GB2362646A (en)	2000-05-26	2001-11-28	Warner Lambert Co	Cyclic amino acid derivatives useful as pharmaceutical agents
GB2365425A (en) *	2000-08-01	2002-02-20	Parke Davis & Co Ltd	Alkyl amino acid derivatives useful as pharmaceutical agents
US20020099013A1 (en) *	2000-11-14	2002-07-25	Thomas Piccariello	Active agent delivery systems and methods for protecting and administering active agents
IL145584A0 (en) *	2000-10-02	2002-06-30	Pfizer Prod Inc	Nmda nr2b antagonists for treatment
US20020165246A1 (en) *	2001-03-05	2002-11-07	Andrew Holman	Administration of sleep restorative agents
NZ529173A (en) *	2001-05-25	2005-07-29	Warner Lambert Co	Stable liquid pharmaceutical composition comprising a GABA analog i.e. gabapentin or pregabalin, and a polyhydric alcohol e.g. glycerol, xylitol, sorbitol, mannitol

2003
- 2003-12-03 KR KR1020057010833A patent/KR20050085636A/ko not_active Ceased
- 2003-12-03 MX MXPA05006320A patent/MXPA05006320A/es active IP Right Grant
- 2003-12-03 RU RU2005118081/14A patent/RU2353358C2/ru not_active IP Right Cessation
- 2003-12-03 BR BR0317253-8A patent/BR0317253A/pt not_active IP Right Cessation
- 2003-12-03 CA CA002505788A patent/CA2505788A1/en not_active Abandoned
- 2003-12-03 EP EP09175270A patent/EP2172197A1/en not_active Withdrawn
- 2003-12-03 NZ NZ540591A patent/NZ540591A/en unknown
- 2003-12-03 JP JP2005502471A patent/JP2006513257A/ja active Pending
- 2003-12-03 PL PL377520A patent/PL377520A1/pl not_active Application Discontinuation
- 2003-12-03 EP EP03813230A patent/EP1572188A1/en not_active Withdrawn
- 2003-12-03 CN CN201010165706A patent/CN101862317A/zh active Pending
- 2003-12-03 WO PCT/IB2003/005712 patent/WO2004054566A1/en not_active Ceased
- 2003-12-03 AU AU2003303040A patent/AU2003303040B2/en not_active Ceased
- 2003-12-12 TW TW092135197A patent/TW200423925A/zh unknown
2005
- 2005-05-10 NO NO20052264A patent/NO20052264L/no not_active Application Discontinuation
2008
- 2008-10-13 RU RU2008140653/15A patent/RU2008140653A/ru unknown
2009
- 2009-04-20 US US12/426,501 patent/US20090203782A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1572188A1 (en)	2005-09-14
AU2003303040B2 (en)	2009-04-23
JP2006513257A (ja)	2006-04-20
US20090203782A1 (en)	2009-08-13
TW200423925A (en)	2004-11-16
WO2004054566A1 (en)	2004-07-01
NZ540591A (en)	2008-03-28
EP2172197A1 (en)	2010-04-07
PL377520A1 (pl)	2006-02-06
CN101862317A (zh)	2010-10-20
CA2505788A1 (en)	2004-07-01
NO20052264L (no)	2005-09-12
RU2353358C2 (ru)	2009-04-27
MXPA05006320A (es)	2005-08-26
BR0317253A (pt)	2005-11-01
AU2003303040A1 (en)	2004-07-09
KR20050085636A (ko)	2005-08-29
RU2008140653A (ru)	2010-04-20
RU2005118081A (ru)	2006-01-20

Publication	Publication Date	Title
DK1663978T3 (da)	2008-04-07	Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20052760D0 (no)	2005-06-07	Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
NO20052796D0 (no)	2005-06-09	Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20050570L (no)	2005-03-04	Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
ZA200504724B (en)	2009-01-28	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
DE60319865D1 (de)	2008-04-30	Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
NO20040097L (no)	2004-03-01	Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20041216L (no)	2004-05-05	Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
IS8451A (is)	2006-05-11	Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is)	2006-04-12	Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
DK1459750T3 (da)	2005-08-15	(S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
NO20043085L (no)	2004-07-13	Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
NO20055152D0 (no)	2005-11-03	Karbonstyrilderivater og humor stabiliserende midler for behandling av humor forstyrrelser
EA200500098A1 (ru)	2005-08-25	Лекарственное средство и способ лечения патологического синдрома
IS7699A (is)	2005-02-17	Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
NO20033854L (no)	2003-10-28	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20014648L (no)	2001-11-22	Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer
NO20041214L (no)	2004-06-24	Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
DK1478438T3 (da)	2012-08-27	Fremgangsmåder og sammensætninger til behandling af astma
NO20033498L (no)	2003-08-07	Fremgangsmåte for behandling og törking av trevirke
NO20015772L (no)	2002-01-22	Forbindelser og fremgangsmåter for behandling av post- traumatisk stress-syndrom
NO20051521D0 (no)	2005-03-22	Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
NO20053874D0 (no)	2005-08-18	Formulering og metoder for behandling av thrombocytemi
NO20052264D0 (no)	2005-05-10	Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser

Legal Events

Date	Code	Title	Description
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application